Prevail Global Study (NCT06535854)
A Randomized Controlled Study of the Prevail Drug-Coated Balloon in Subjects With In-stent Restenosis and a Single Arm Prospectively Enrolled Study of the Prevail Drug-Coated Balloon for de Novo Lesions in Small Vessel Disease (Prevail Global).
🩺 Plain-English Summary (8th-Grade Level)
The purpose of the study is to evaluate the clinical safety and efficacy of the Prevail DCB.
Who can join: Review the eligibility criteria below.
Location: The University of Alabama at Birmingham — Birmingham, Alabama
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (51 Sites)
Showing the first 25 of 51 sites.
- The University of Alabama at Birmingham — Birmingham, Alabama
- Huntsville Hospital — Huntsville, Alabama
- Carondelet Saint Marys — Tucson, Arizona
- John L McClellan Memorial Veterans Hospital — Little Rock, Arkansas
- Stanford Hospital & Clinics — Stanford, California
- Medical Center of the Rockies — Loveland, Colorado
- Medstar Washington Hospital Center — Washington D.C., District of Columbia
- BayCare Health System — Clearwater, Florida
- North Florida Regional Medical Center — Gainesville, Florida
- University of Miami Hospital — Miami, Florida
- Emory University Hospital Midtown — Atlanta, Georgia
- Piedmont Atlanta Hospital — Atlanta, Georgia
- Advocate Illinois Masonic Medical Center — Chicago, Illinois
- Midwest Cardiovascular Institute — Naperville, Illinois
- Parkview Health — Fort Wayne, Indiana
- University of Kansas Medical Center — Kansas City, Kansas
- Kansas City Heart Rhythm Institute (Midwest Heart and Vascular Specialist) — Overland Park, Kansas
- Ascension Via Christi Saint Francis — Wichita, Kansas
- Saint Elizabeth Healthcare — Edgewood, Kentucky
- University of Michigan Health System - University Hospital — Ann Arbor, Michigan
- Corewell Health — Grand Rapids, Michigan
- Saint Joseph Mercy Ann Arbor — Ypsilanti, Michigan
- M Health Fairview Clinic — Edina, Minnesota
- CentraCare Heart & Vascular Center MN - Saint Cloud Hospital — Saint Cloud, Minnesota
- Saint Lukes Mid America Heart Institute — Kansas City, Missouri
📞 Contact the Study Coordinator
Phone: +31 (0)43.356.6566
Email: rs.prevailglobal@medtronic.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Coronary Artery Disease
- Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (FAME) 3 Extended — Stanford, California
- Genomic Investigation of Cardiovascular Diseases — La Jolla, California
- Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health — Boston, Massachusetts
- A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD — Mobile, Alabama
- Firehawk Rapamycin Target Eluting Coronary Stent North American Trial — Birmingham, Alabama
- Precision PCI Registry — Gainesville, Florida
Explore by condition: All Coronary Artery Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.